Inhaler
Latest Novartis AG Patents:
- Pharmaceutical products and stable liquid compositions of IL-17 antibodies
- Immunoglobulin variants
- Compounds and compositions as Sppl2a inhibitors
- Regimens and methods of treating multiple sclerosis using ofatumumab
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant fc fusion proteins
Description
The broken lines shown in
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D656606
Type: Grant
Filed: Jun 21, 2011
Date of Patent: Mar 27, 2012
Assignee: Novartis AG (Basel)
Inventors: John Palmer-Felgate (Horsham), Steven Dudley (Horsham), Shimi Barr (Randwick)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Design IP
Application Number: 29/394,724
Type: Grant
Filed: Jun 21, 2011
Date of Patent: Mar 27, 2012
Assignee: Novartis AG (Basel)
Inventors: John Palmer-Felgate (Horsham), Steven Dudley (Horsham), Shimi Barr (Randwick)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Design IP
Application Number: 29/394,724
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)